3 Min Read
Pharma leaders today face a growing paradox: patients have endless access to information, yet struggle to find clarity, trust, and connection.
At Fierce Pharma Week in Philadelphia, The Harris Poll shared how the future of healthcare marketing lies in turning research into relevance. Here’s a look at how we are helping pharmaceutical and healthcare brands cut through complexity, engage with purpose, and deliver measurable results.
The New Reality: Fear, Misinformation, and Disconnection
Today’s healthcare landscape is shaped by cultural tension and systemic distrust:
- Anxieties remain high: economic instability, political division, and AI-fueled disruption are reshaping how people live, work, and seek care.
- Misinformation is pervasive: over half of physicians say patients have been influenced by false or misleading information in the past year.
- Patients feel increasingly isolated: nearly two-thirds of Americans say wellness trends on social media feel more approachable than medical professionals.
For pharma brands, this creates both risk and responsibility: it’s no longer enough to deliver breakthrough therapies. You must also deliver relevance, trust, and clarity.
The Omnichannel Challenge
While pharma has invested heavily in omnichannel strategies, most leaders still aren’t seeing the full return:
- 53% cite internal silos as the biggest barrier to impact.
- 61% say teams lack access to shared data.
- 64% report a misalignment between digital metrics and strategic KPIs.
This gap doesn’t just stall progress, it leads to missed opportunities, wasted spend, and fragmented patient experiences.
A Better Path Forward: Connecting Data, Teams, and Stories
Progress lies in integration:
- Breaking silos to align insights across functions.
- Embedding context from culture, society, and real-life experiences.
- Translating findings into human-centered narratives that resonate.
For example: We partnered with a healthcare non-profit facing stagnant brand growth. Through a custom brand tracker, we identified high-potential audience segments and uncovered where their messaging was missing the mark. Those insights became the foundation for a new communications strategy, while our partners at Assembly (Stagwell) brought the strategy to life through targeted activation.
The result? Higher CTRs, lower CPCs, and improved engagement across key benchmarks.
Why It Matters
With 30% of the world’s data now coming from healthcare, most of it still underutilized, pharma’s next competitive advantage won’t come from more data, but smarter integration.
Those who win will be the ones who turn research into relevance: connecting dots across people, platforms, and performance to drive better outcomes for both business and patients.
What’s Next?
If you’re rethinking how your organization uses research to inform strategy, messaging, and measurable action, we’d love to connect.
Let’s turn insight into impact together! Fill out the following contact form and one of our reps from Fierce Pharma Week will reach out to you.
